goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
     HOME      ABOUT  I H S   SITE MAP     HELP
goto Health and Human Services home page goto Health and Human Services home page

HIV Infection in Pregnancy

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules MCH - Perinatologist Corner C.E.U/C.M.E.
goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
     HOME      ABOUT  I H S   SITE MAP     HELP
goto Health and Human Services home page goto Health and Human Services home page

HIV Infection in Pregnancy

Contact Us

MCH Website Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Maternal Child

Maternal Child HealthPerinatologist Corner ‹ C.E.U./C.M.E. Modules

Perinatologist Corner - C.E.U/C.M.E. Modules

HIV Infection in Pregnancy

Sponsored by The Indian Health Service Clinical Support Center

4. Read the material on zidovudine

Prevention of vertical transmission of H.I.V. from mother to infant is the major goal of this protocol. In 1994 the 076 study clearly demonstrated that zidovudine (Z.D.V.) treatment of the mother during pregnancy and in labor, and treatment of the infant in the neonatal period, was able to reduce the transmission rate from 25% to 8%. This protocol should be made available to all known H.I.V.-infected patients, regardless of viral load, CD4+ counts, or other drug therapy:

Antepartum: Oral administration of 100 mg zidovudine 5 times daily, initiated at 14-34 weeks gestation and continued throughout the pregnancy.

Intrapartum: Intravenous administration of Z.D.V. in a 1-hour initial dose of 2 mg/kg, followed by a continuous infusion of 1 mg/kg/hr until delivery. (If planned cesarean, Z.D.V. should be begun 3 hours prior to surgery.)

Postpartum: Oral administration of ZDV syrup 2 mg/kg q6h to the newborn for the first 6 weeks of life beginning 8-12 h after birth. (If unable to take p.o., give Z.D.V. 1.5 mg/kg I.V. q6h.)

3. Background ‹ Previous | Next › 5. Other antiretrovirals

up arrow Return to top of page

Accessibility  --  Disclaimer  --  Website Privacy Policy  --  Freedom of Information Act
Kids Page  --  Frequently Asked Questions  --  USA.gov  --  HHS

This file last modified: Friday July 6, 2007  3:02 PM